Salt CompositionYou Searched
CA Retrans Capsule
AMPS Biotech Pvt. Ltd.
₹1,175
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Acne / Acute promyelocytic leukaemia
Customers also bought
More About CA Retrans
Benefits
In Treatment of Acne : CA Retrans Capsule is a form of vitamin A. It helps treat acne by clearing skin pores and preventing spots or pimples from appearing. It usually takes several weeks to have a noticeable effect so keep using it even if it appears not to be working. Sometimes acne may get worse before it gets better, however, with proper use, your skin will get clearer. The earlier you start using it, the less likely you are to get scars. This medicine will help improve your mood and uplift your confidence as your skin becomes acne-free. It should not be used if you have eczema or sunburned skin.
Side Effects
Side effects of CA Retrans Capsule The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of CA Retrans Headache Fever Bone pain Rash Visual impairment Hair loss Increased sweating Mucosal inflammation Erythema (skin redness)Skin irritation Dry skin Dry lips Pale red skin Increased sensitivity to light
How to use
How to use CA Retrans Capsule Follow your doctor's guidance regarding the dose and duration of this medication. CA Retrans Capsule is to be taken with food.
How it works
How CA Retrans Capsule works CA Retrans Capsule is a form of vitamin A. To treat blood cancer, it works by slowing the growth of certain types of diseased blood cells, and promotes the growth of normal, mature cells in the bone marrow and blood. This helps to treat blood cancer (acute promyelocytic leukemia).
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with CA Retrans Capsule . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
CA Retrans Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
CA Retrans Capsule is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
CA Retrans Capsule may cause side effects which could affect your ability to drive.Your ability to drive might be impaired while you are taking CA Retrans Capsule, especially if you are feeling dizzy or have a severe headache.
There is limited information available on the use of CA Retrans Capsule in patients with kidney disease. Doctor consultation is advised.However, a cautious use of this medicine is advised in these patients.
There is limited information available on the use of CA Retrans Capsule in patients with liver disease. Doctor consultation is advised.However, a cautious use of this medicine is advised in these patients.
What if I forget to take it?
If a dose of CA Retrans Capsule is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
36/22, Near Annapurna Building, J B Nagar, Andheri East, Mumbai City, Maharashtra, 400069
References
Burkhart C, Morrell D, Goldsmith L. Dermatological Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1810
Sardana K, Madan A. How to Treat Acne. Sardana K, editor. In: Clinical Approach to Acne Vulgaris. 1st ed. New Delhi: CBS Publishers & Distributors Pvt. Ltd.; 2015. pp. 35-36
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1395
Tretinoin. Nutley, New Jersey: Roche Laboratories Inc.; 2004 (23 Jul. 2019)
Tretinoin. Mesekenhagen Germany: Cheplapharm Arzneimittel GmbH; 1996 (03 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (03 Apr. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
